JABLX | RLBGX | JABLX / RLBGX | |
Total Expense Ratio | 0.62 | 0.25 | 248% |
Annual Report Gross Expense Ratio | 0.62 | 0.25 | 248% |
Fund Existence | 32 years | 16 years | - |
Gain YTD | 0.763 | 4.592 | 17% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.97B | 244B | 4% |
Annual Yield % from dividends | 1.96 | 2.23 | 88% |
Returns for 1 year | 5.46 | 5.63 | 97% |
Returns for 3 years | 33.77 | 33.78 | 100% |
Returns for 5 years | 47.24 | 40.35 | 117% |
Returns for 10 years | 92.29 | 60.87 | 152% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETNHX | 32.96 | -0.23 | -0.69% |
Eventide Healthcare & Life Sciences N | |||
PIGDX | 16.26 | -0.16 | -0.97% |
Federated Hermes International Growth IS | |||
AFICX | 83.75 | -0.93 | -1.10% |
American Funds Fundamental Invs C | |||
JAWWX | 117.22 | -1.52 | -1.28% |
Janus Henderson Global Research T | |||
HFAHX | 15.13 | -0.21 | -1.37% |
Hartford Schroders Intl Cntrrn Val Y |